Profile
Paul F.
Engler is the founder of Cactus Feeders, Inc. which was founded in 1975, where he holds the title of Chairman.
Currently, he is a Director at Toragen, Inc. since 2022.
In the past, he worked as a Director at GlobeSecNine, Inc.
Paul F. Engler active positions
| Companies | Position | Start |
|---|---|---|
Cactus Feeders, Inc.
Cactus Feeders, Inc. Agricultural Commodities/MillingProcess Industries Provides cattle feeding services | Founder | 1974-12-31 |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Engages in developing, repurposing and commercializing cancer drugs | Director/Board Member | 2022-08-14 |
Former positions of Paul F. Engler
| Companies | Position | End |
|---|---|---|
GlobeSecNine, Inc.
GlobeSecNine, Inc. Investment ManagersFinance GlobeSecNine invests in both public and private companies located in the United States. The firm targets companies operating in the fields of defense & classified services, port & transportation system security, agriculture, water and food safety sectors. The firm participates in MBOs, consolidations, build-ups and growth capital transactions. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Cactus Feeders, Inc.
Cactus Feeders, Inc. Agricultural Commodities/MillingProcess Industries Provides cattle feeding services | Process Industries |
GlobeSecNine, Inc.
GlobeSecNine, Inc. Investment ManagersFinance GlobeSecNine invests in both public and private companies located in the United States. The firm targets companies operating in the fields of defense & classified services, port & transportation system security, agriculture, water and food safety sectors. The firm participates in MBOs, consolidations, build-ups and growth capital transactions. | Finance |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Engages in developing, repurposing and commercializing cancer drugs | Health Technology |
- Stock Market
- Insiders
- Paul F. Engler
















